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Lactoferrin (Lf) is an iron-binding protein found in high concentrations in mammary secretions but synthesized by many
tissues. Bovine mammary tissue secretes µg/ml mass of Lf in milk, but during involution and prepartum periods,
20–80 mg/ml concentrations may be observed. While a number of functions have been ascribed to lactoferrin, only the
antimicrobial and lymphocyte interactions have compelling experimental evidence of support. We report a new finding that
lactoferrin binds to insulin-like growth factor binding protein-3 (IGFBP-3) and not to other mammary secreted IGFBPs
(IGFBP-2, -4, & -5). Furthermore, bovine Lf (bLf) is found associated with membranes of mammary cells. We demonstrate
that bovine Lf competes with IGF for binding to IGFBP-3 with ED50 competition of 3 µg/ml and displacement of 1 mg/ml
to monomeric bLf. The tetrameric form that is favored by high concentrations of Lf and calcium, does not appear to bind
IGFBP-3. Both IGFBP-3 and Lf have nuclear localization sequences that are reported to be key components of nuclear
localization of proteins. We demonstrate that extracellular IGFBP-3 binds to membrane Lf and that Lf is the key to the entry
of IGFBP-3 to mammary cellular nucleus. Additionally, we have shown that the internalization of Lf requires the presence
of retinoids that also induces both IGFBP-3 and Lf synthesis in primary cultures of bovine mammary epithelial cells.  We
hypothesize a new role for Lf in the regulation and integration into the IGF System.
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Mécanismes d’action de la lactoferrine au niveau mammaire : interactions avec l’IGFBP-3. La lactoferrine (Lf) est une
protéine de liaison du fer trouvée en concentrations élevées dans les sécrétions mammaires mais synthétisées également par
de nombreux autres tissus. Les tissus mammaires bovins secrètent dans le lait des quantités de Lf à des concentrations de
l’ordre du µg/ml alors que pendant les périodes d’involution et pre-partum, ces concentrations fluctuent entre 20 et 80 mg/ml.
Bien qu’un  certain nombre de fonctions  biologiques de  la Lf  ont été  décrites, seules les activités antimicrobiennes et
l y m p h o c i t a i r e s ont été clairement démontrées expérimentalement. Nous décrivons une nouvelle propriété de la Lf laquelle se
lierait uniquement à la protéine de liaison 3 de l’insulin-like growth factor-I (IGFBP-3) et non aux autres protéines de liaison
de l’IGF-I sécrétées par la glande mammaire (IGFBP-2, -4 & -5). Par ailleurs, la lactoferrine bovine se fixe aux membranes
des cellules de la glande mammaire. Nous avons démontré que la Lf bovine (bLf) entre en compétition avec l’IGF pour la
liaison avec l’IGFBP-3 avec un ED50 de compétition de 3 µg/ml et un déplacement de 1 mg/ml de la bLf monomérique. La
forme tétramérique dont l’obtention est favorisée par des concentrations élevées en Lf et en calcium, ne paraît pas se lier à
l’IGFBP-3. Tant l’IGFBP-3 que la Lf présentent dans leurs séquences des signaux de translocation dans le noyau qui militent
en faveur d’une localisation nucléaire de ces protéines. Nous avons démontré que l’IGFBP-3 extracellulaire se fixe à la Lf de
membranes et que la Lf joue un rôle central dans l’internalisation de l’IGFBP-3 dans le noyau des cellules mammaires. De
plus, nous avons observé que l’internalisation de la Lf nécessite la présence de rétinoïdes lesquels induisent aussi bien la
synthèse d’IGFBP-3 que de Lf par les cellules épithéliales mammaires placées en culture primaire. En conclusion, nous
formulons l’hypothèse d’un nouveau rôle de la Lf dans la régulation et l’intégration du système IGF.
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1. INTRODUCTION
Lactoferrin (Lf) is an iron-binding glycoprotein found
in high concentrations in mammary secretions and to a
lesser extent in exocrine secretions of mammals and is
released from neutrophilic granules during inflammation.
However, Lf mRNA expression appears in almost all
normal human tissues (Siebert, Huang, 1997).  A l t h o u g h
first isolated and characterized in the 1950s, evidence
for a significant biological function for this protein
remains inadequate except for the bacteriostatic and
immune functions described below.
The many effects of Lf have been recently related
to host defense mechanisms. Lactoferrin is associated
with the activation of natural killer cells (Shau et al.,
1992),  induction  of  colony-stimulating  activity
(Sawatzki, Rich, 1989), activation of leukocytes and
monocytes (Gahr et al., 1991), potentiation of macro-
phage cytotoxicity (Gahr et al., 1991), maturation of
splenic B cells (Zimecki et al., 1995), among other
functions (Baveye et al., 1999).
While the bacteriostatic capacity of Lf stemming
from its sequestering of iron is established, additional
roles for lactoferrin have been described that appear to
be independent of iron. Lactoferrin has been shown, in
some cell systems, to stimulate growth of the cells
(Nichols et al., 1990). However, growth stimulation
reports  are  positive  (Azuma  e t a l .,  1989),  some
demonstrating inhibition of growth (Rejman e t a l ., 1992),
and still others with no effect (Amouric et al., 1984).
In support of a cellular function, Lf receptors have
been reported in intestinal brush border membranes
(Gislason et al., 1993; Kawakami, Lonnerdal, 1991)
with reported Kd of around 1–3 µM.  Monocytes also
have been shown to bind Lf with higher affinities
(10–9M) (Birgens et al., 1984) and other leukocytes
with lower affinity (Campbell, 1982).
2. REGULATION  OF LACTOFERRIN  AND
IGFBP SYNTHESIS 
The regulation of lactoferrin is tissue specific. While
Lf synthesis is stimulated by 17b-estradiol in uterine
tissue at the transcription level, the mammary gland is
unaffected by this hormone (Lonnerdal, Iyer, 1995).
On the other hand, mouse mammary tissue Lf has been
shown to be responsive to prolactin (Green, Pastewka,
1978). Interestingly, the expression of Lf is decreased
or absent in most breast cancer cell lines compared to
normal cells and tissue (Campbell e t a l ., 1992).  Recent
studies  by  Close  e t a l . (1997)  indicate  that  Lf
expression is partially mediated by changes in cell
shape and cytoskeleton.
Figure 1 demonstrates that the appearance of Lf in
media from primary culture of bovine mammary cells
(MEBo cells) takes more than four days when cultured
on plastic and is stimulated by the application of all
trans retinoic acid (atRA). The time element of Lf
expression is likely related to cytoskeleton interactions
(Close et al., 1997) as primary cells lay down an
extracellular matrix with time in culture. The atRA
response supports the report of a retinoic acid response
element (RARE) in the 5’ flanking region of the
lactoferrin gene (Lee et al., 1998).
Additionally, figure 2 shows that the application of
atRA to growth stimulated MEBo cells also results in
a growth inhibition response reported for many cell
cultures (Fontana e t a l ., 1991) and the bovine mammary
cell  line  MAC-T cells  (Woodward  e t a l .,  1996).
Furthermore, atRA also is known to stimulate the
synthesis and secretion of IGFPB-3 (Adamo et al.,
1992) and this is also demonstrable with MEBo cells
(Baumrucker et al., 1999). The effects of atRA (cell
growth inhibition; changes in levels of Lf and IGFBPs)
on mammary cells (Adamo et al., 1992; Gucev et al.,
1996; Liu et al., 1997) appear to be associated. Our
information presented herein provides direct evidence
of a linkage between retinoic acid, Lf, IGFBP-3 and
associates these changes with cell mechanisms for
reduced growth or increased apoptosis.
Days in culture
50 ng Insulin/
10 ng EGF
SFM ± atRA
Figure 1. All trans retinoic acid (atRA) stimulates the
appearance of Lf in primary cultures of MEBo cells. Cells
were cultured in DME/F12 on plastic for 4 days with insulin
and epidermal growth factor (EGF) to stimulate cellular
growth. Culture for days 4 to 8 was conducted in serum free
media (SFM) ± 1 µM atRA. Lf was detected in Western blots
with a bLf antibody donated by Dr. Floyd Schanbacher,
Ohio State University — Tous les acides retinoïques trans
(atRA) stimulent l’apparition de Lf dans les cultures primaire s
de cellules MEBo. Les cellules étaient cultivées sur plastique
en présence de DME/F12 pendant 4 jours ainsi que d’insuline
et  du  facteur de  croissance épidermique (EGF) afin de
stimuler la croissance cellulaire. La culture cellulaire allant
de 4 à 8 jours était réalisée sur un milieu sans sérum (SFM)
avec ± 1 µM d’atRA. La Lf était détectée par Western blots
avec un anticorps dirigé contre la Lf bovine et fourni par le
Dr Floyd Schanbacher, Ohio State University.Lactoferrin and IGFBP-3 interactions 7
3. CORRELATION  BETWEEN  IGFBP-3  AND
LACTOFERRIN
Some interesting physiological connections have been
reported between IGFBP-3 and Lf. For example,
fluctuation in the levels of Lf in the bovine lactation
cycle corresponds well to that of IGFBP-3 (Campbell
e t a l ., 1991). During involution and prepartum periods,
IGFBP-3 (Vega et al., 1991) and Lf (Talhouk et al.,
1990) are high in expression and high concentrations
appear in mammary secretions. During involution, Lf
concentration in the secretion of dairy cows is enormously
variable and can reach extremely high concentrations
(~10% solution of Lf) in some cows (Figure 3).
Furthermore, in certain pathological conditions such as
inflammation,  an  increased  secretion of  IGFBP-3
(Schuster e t a l ., 1995) accompanies the elevated secretion
of Lf that is independent of the status of the epithelial
tight junctions. F i g u re 4shows this timing relationship.
While the uninfected lactating mammary gland has
low levels of BSA, Lf and IGFBP-3 in milk, an
E s c h e r i c h i a c o l i induced inflammation response shows
the increase in serum BSAappearing in milk within 20
hours  of  treatment,  indicative  of  the  relaxation o f
epithelial tight junctions. This response is reversed within
60 hours and the milk concentration of BSA returns to
the  concentrations  that  existed  prior  to  infection.
I n t e r e s t i n g l y, bIGFBP-3 increases in milk with a pattern
similar to BSA. IGFBP-3 is found in blood and extra-
cellular fluids at concentrations greater than that of
milk (Gibson et al., 1999). However after the tight
junctions reform (> 6 0 h), IGFBP-3 continues to appear
in milk at elevated concentrations. Lactoferrin, on the
other hand, is low in blood and extracellular fluids and
therefore does not show increased concentrations during
relaxation of the tight junctions. However, after the tight
junction recovery period, similar to IGFBP-3, Lf concen-
trations become elevated in milk for extended periods.
Figure 2. All trans retinoic acids (atRA) inhibit mammary
cell proliferation. MEBo cells were grown on plastic and
stimulated to grow with 50 ng/ml insulin and 10 ng/ml of
EGF. Treatment with atRA (1 µM) started on day 0 of
culture — Tous les acides retinoïques trans (atRA) inhibent
la prolifération des cellules mammaires. Les cellules MEBo
c roissent sur plastique et sont stimulées dans leur cro i s s a n c e
par 50 ng/ml d’insuline et 10 ng/ml d’EGF. Le traitement
au moyen d’atRA (1µM) débutait au jour 0 de la culture.
Days in culture
Week following cessation of milking
(involution)
F i g u re 3 .Variation of the concentrations of lactoferrin in the
secretions of dairy cows during involution. Data are plotted
from information obtained from Welty et al. (1976) —
Variation  des  concentrations  de  lactoferrine  dans  les
sécrétions des vaches laitières pendant l’involution. Les
résultats sont reproduits à partir d’informations obtenues
de Welty et al. (1976).
Time post infection (hour)
F i g u re4 .Appearance of BSA, Lf and IGFBP-3 in the secretions
of dairy cows after an E. coli induced inflammation. Data
are replotted from Harman et al. (1976) and Schuster et al.
(1995) — Apparition de sérum albumine bovine (BSA),
l a c t o f e rrine (Lf) et d’IGFBP-3 dans les sécrétions de vaches
laitières après induction d’une inflammation par E. coli.
Les  résultats  sont  re p roduits  à  partir  d’informations
obtenues de Harman et al. (1976) et Schuster et al. (1995).8 Biotechnol. Agron. Soc. Environ. 2000 4 (1), 5–12 CR. Baumrucker
4. AN  IGFBP-3  BINDING  PROTEIN  IN
MAMMARY CELL MEMBRANES
At the 1998 Endocrine Meetings (Gibson et al., 1998),
we reported that [125I] recombinant human (rh)IGFBP-
3 bound to a glycosylated ~60 to 70 kDa membrane
protein from primary cultures of bovine mammary
cells. A report by Cohen (1998) recently suggested
transferrin as a IGFBP-3 “partner protein” prompting
us to consider the > 60 kDa glycosylated protein in
mammary membranes to be lactoferrin. We have
recently positively identified this membrane protein as
lactoferrin  by  immunoprecipitation  (Baumrucker
et al., 1999). Additionally, we have shown that [125I]
rhIGFBP-3 binds to Lf regardless of its source (Sigma
vs. Fluka) or animal origin (human vs. bovine). It
appears that iron-containing holo-Lf binds more [125I]
rhIGFBP-3 compared to apop-lf and transferrin lacks
the ability to bind [125I]-rhIGFBP-3. The relationship
of Lf to transferrin is not well understood (Baker et al.,
1998). While the two proteins share some functional
roles, there are very distinct differences with specific
roles ascribed to one or the other protein. Our finding
that binding to IGFBP-3 is restricted to Lf but not to
transferrin  supports  the  protein  differences  and
suggests a specific role of Lf
To demonstrate more aspects of [125I] rhIGFBP-3
binding to Lf, we used a modified dot Western blot.
Lactoferrin (20 µg) was spotted onto the membrane
and [125I]rhIGFBP-3 or [125I]rhIGF-II was allowed to
bind in the absence or presence of unlabeled rhIGFBP-
3 or rhIGF-II. While [125I]rhIGF-II did not bind to Lf,
[125I]rhIGFBP-3 did bind bLf. Binding specificity was
demonstrated by the addition of unlabeled rhIGFBP-3
that blocked tracer binding. The application of rhIGF-
II was shown to decrease [125I]rhIGFBP-3 binding,
presumably by binding to IGFBP-3 and preventing
formation of the Lf:IGFBP-3 complex. The finding
that IGF-II interacts with the IGFBP-3:Lf binding was
an important observation.
To confirm that this is a competitive interaction,
we again utilized a Western dot blot. Data indicated
that Lf competes or displaces [125I]IGFs for binding to
nitrocellulose-bound IGFBP-3. We have shown that Lf
competes with IGF-II:IGFBP-3 binding with an ED50
of approximately 3 µg/ml and displaces bound IGF-II
from the IGF:IGFBP-3 binding with an ED50 of
approximately 1 mg/ml. This is well within the range
of Lf concentrations that exist within mammary tissue
in various physiological states (Neville et al., 1998).
We propose that Lf interacts with IGFBP-3 and IGF-II
in the manner shown in the equation above and we
also assume that such an interaction would also be
shown for IGF-I.
Thus, the synthesis and secretion of mammary cell
Lf will likely have a role in the IGF system and
ultimately, cell growth and survival. We hypothesize
that  the  enhanced  production  of  Lf  during  the
immediate pre-partum period and during involution
(Nuijens et al., 1996) will free IGFs (both IGF-I and
IGF-II) from their association with IGFBP-3. This
mechanism could provide an increased stimulation
from type 1 IGF receptor and lead to increased cell
growth and decreased apoptosis.
5. APPLICATION  OF LF TO  PRIMARY
C U LTURES  OF MEBO  CELLS  STIMULAT E S
INCREASED  CELL NUMBERS
Reports of Lf stimulatory effect upon epithelial cell
growth are not clear with both positive and negative
reports. Figure 5 shows data that the application of
holo bovine Lf (bLf) to a bovine mammary cell
(MEBo) culture increases cell numbers compared to
controls, while transferrin has no growth promoting
effects. The application of insulin/EGF demonstrates a
high level of growth promotion. We hypothesize that
this  Lf  effect  is  one  related  to  the  competitive
IGF
IGF + IGFBP-3:Lf              IGF:IGFBP-3 + Lf.
Lf
Lactoferrin concentration
µg/ml
hour
Tf Ins/EGF
Figure 5. Lactoferrin stimulates the growth of MEBo cells.
Cells were grown on plastic for 72 hours and were treated
with Lf (0, 100 and 500 µg/ml), 500 µg/ml of transferrin, or
50 ng/ml of insulin and 10 ng/ml of EGF — La lactoferrine
stimule la croissance des cellules MEBo. Les cellules M E B o
c roissaient sur plastique pendant 72 heures et étaientmises
en présence de Lf (0, 100 et 500 µg/ml), 500 µg/ml de
transferrine ou 50 ng/ml d’insuline et 10 ng/ml d’EGF.Lactoferrin and IGFBP-3 interactions 9
interaction of the Lf/IGFBP-3/IGF diagramed above.
MEBo cells synthesize and secrete both IGFBP- 3
(Gibson et al., 1999) and IGF-II (Baumrucker et al.,
1993). The application of Lf to the cultures would be
expected to cause a competitive release of IGF-II from
the IGFBP-3:IGF-II complex and allow for IGF-II
stimulation of  increased cell number v i a the mammary
cell type I IGF receptor. However, this mechanism of
action would be dependent upon the mass of IGF and
IGFBP-3 that any cell secretes or has present in its
environment.  Because this is likely inconsistent, the
variation of results concerning Lf growth promoting
effects discussed earlier may be explained.
6. NUCLEAR  APPEARANCE  OF IGFBP-3:LF
COMPLEXES
In recent studies with MCF-7 cells, we have shown
that these breast cancer cells translocated extracellular
IGFBP-3 into the nucleus that is dependent upon the
presence of Lf and treatment with atRA (Baumrucker
et al., 1999). We utilized Texas Red (TR)-labeled
rhIGFBP-3 and fluorescein (FITC)-labeled b-Lf in
studies with MEBo cells. Cells were cultured for 8
days in SFM ± atRA and at the initiation of uptake
studies, the culture media was changed to fresh SFM
with the addition of the labeled proteins for 2 hours.
Cells were then fixed, stained with DAPI (nuclear
stain) and photomicrographs taken with an inverted
fluorescent microscope.
Cells cultured without atRA(control) showed light
traces of FITC-bLf in the cytoplasm of cells when
FITC-bLf was applied. The control cells also show a
small  amount  of  TR-IGFBP-3  appearance  in  the
nucleus when IGFBP-3 was applied. However when
both FITC-Lf and TR-IGFBP-3 were added together
under control conditions, a much stronger signal was
observed in the cytoplasm of the cells. Some nuclear
occurrence of both Lf and IGFBP-3 could also be
observed 
Differences in cellular uptake of Lf and IGFBP-3
when the cells are cultured in the presence of atRA
were also observed. Cells take up the FITC-labeled Lf
and the location is clearly more nuclear when treated
with atRA. The uptake of TR-IGFBP-3 in atRAtreated
cells appears to be similar to that of the control cells
with only some cellular nuclei showing the presence
of the protein. However, when both FITC-Lf and TR-
IGFBP-3 were added to atRA treated cells, a much
stronger and simultaneous signal was observed in the
nucleus of the treated cells. This was in contrast to the
controls that showed strong cytoplasmic signal, but
only minor nuclear signal.
The photomicrographs described above indicate
that the Lf and IGFBP-3, which we have shown to
form a complex, are cooperative in the capacity to be
taken  up  into  bovine  mammary  epithelial  cells.
Additionally, atRA treatment causes changes in the
distribution of these proteins that may or may not be
linked to cellular mechanisms of action. Obviously,
these descriptions demonstrate coincidental events and
do not demonstrate specific mechanisms of action.
However, we believe that these events may, at least
partially, explain a mechanistic action of atRA upon
nuclear IGFBP-3 and Lf in bovine mammary cells.
7. RETINOIC  A C I D / V I TAMIN  A I M PACTS  IN
DAIRY COWS
While we have shown a connection between atRA,
bLf and IGFBP-3, little is known of potential in vivo
effects of such interations. All trans retinoic acid is
part of the retinoic acid family of steroid endocrine
factors. Both carotenes and vitamin A are dietary
components that are metabolized to active retinoid
components. Vitamin A and its derivatives have many
functions  including  immune  alterations,  vision
impacts,  reproductive  effects  and  epithelial  cell
maintenance (Weis, 1998). While supplementation of
vitamin Aor b-carotene has been prescribed during the
dry period in order to increase colostral vitamin A for
the sake of transfer to the newborn, other impacts upon
mammary function have been explored. While the
mammary immune boost capacity of vitamin Aduring
the dry period is controversial, the study of Oldham
e t a l . (1991)  documented  an  increase  in  milk
production that was not related to differences in
mammary gland health. These authors concluded that
while milk production was not a major objective of
their study, the surprising results warrant additional
research. A later vitamin A/b carotene study with
lactating cows (Michal et al., 1994) did not support an
overall increase in milk production; however, the high
vitamin A treatment did result in greater increases
when considering the initial week of production. The
question of retinoid impact upon dairy cow lactational
production  is  currently  unknown,  but  with  the
evidence that we present herein, a possible mechanism
could be acting via Lf and the IGF system.
The  proposed  model  shown  in  f i g u re 6 i s
hypothesized from our findings with primary cultures
of bovine mammary epithelial cells. Retinoids bind to
nuclear retinoic acid receptors and one of their known
actions is to stimulate the synthesis and secretion of
IGFBP-3. Our data also shows that the appearance of
Lf in conditioned media is also increased by atRA
treatment.  Extracellular  IGFBP-3  is  therefore
available  for  binding  to  IGF  originating  from
autocrine,  paracrine  or  endocrine  sources,  and
therefore  indirectly  has  the  potential  to  alter  the
binding of IGF to the type 1 receptor. When Lf is
present in the extracellular domain it binds IGFBP-3,10 Biotechnol. Agron. Soc. Environ. 2000 4 (1), 5–12 CR. Baumrucker
causing the dissociation of IGF and results in an
IGFBP-3:Lf complex. 
We envision two modes of mechanistic action for
this complex. The IGFBP-3:Lf complex enters the cell
(Figure 6) and nucleus, and together or dissociated,
the protein(s) have impact upon the cell cycle (inhibition
of cell growth) or alteration of apoptotic pathways.
Recently we have shown that the retinoic acid receptors
(a & b) are co-immunoprecipitated when anti-bovine
IGFBP-3 is applied to nuclear extracts of atRA treated
MCF-7 cells (data not shown). This finding of an nuclear
IGFBP-3:RARa and IGFBP-3:RARb association is
supported by a report of a direct functional interaction
between IGFBP-3 and retinoid receptors (Liu et al.,
1999). In this report, IGFBP-3 is reported to bind to
the RXR receptors in F9 embryonic carcinoma cell
line as well as RARE transfected COS7 cells and leads
to modulation of the transcriptional activity of RXR
favoring homodimerization over heterodimerization,
the latter being the typical signaling mechanism in
mammary epithelial cells (Shang et al., 1998; Shang
et al., 1999a; Shang et al., 1999b).
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